Evaluation of asthma control and quality of life after 6 months of treatment with FDC Budesonide/Formoterol-BOREAS study.
P. Bakakos (Athens, Greece), D. Papakosta (Thessaloniki, Greece), E. Zervas (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), A. Ginis (Attica, Greece), M. Bertoli (Attica, Greece), K. Apostolidou (Attica, Greece), S. Loukides (Athens, Greece)
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Session: Asthma treatment: cohorts and real-world studies
Session type: Thematic Poster
Number: 2567
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Bakakos (Athens, Greece), D. Papakosta (Thessaloniki, Greece), E. Zervas (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), A. Ginis (Attica, Greece), M. Bertoli (Attica, Greece), K. Apostolidou (Attica, Greece), S. Loukides (Athens, Greece). Evaluation of asthma control and quality of life after 6 months of treatment with FDC Budesonide/Formoterol-BOREAS study.. 2567
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: